Kyle Hayes

Kyle Hayes has over 20 years of work experience in the pharmaceutical and research industries. Kyle has been working at Mallinckrodt Pharmaceuticals since 2013, where they have held various roles including Associate Director and Senior Manager in the HEOR Value Evidence Generation department. Prior to that, they worked as a Senior Molecular Biologist and Staff Biochemist at the same company, focusing on preclinical nephrology and molecular pathology, respectively. Before joining Mallinckrodt Pharmaceuticals, Kyle worked at Pfizer as a Senior Scientist in the Investigative Pathology group, where they developed and led a core in-situ hybridization lab. Kyle also worked as a Research Scientist at The Virginia Institute of Marine Science.

Kyle Hayes has a strong education history in the field of public health and outcomes research. Kyle is currently a Ph.D. student at Saint Louis University, specializing in Public Health- Outcomes Research. Prior to this, they completed a Master of Science degree in Outcomes Research and Evaluation Sciences at Saint Louis University from 2016 to 2018.

In addition to their expertise in outcomes research, Kyle also has a background in cell and molecular biology, having obtained a Master of Science degree from the University of Missouri-Saint Louis from 2003 to 2006. Furthermore, they hold a Bachelor of Science degree in Biology from Truman State University, which they completed between 1994 and 1998.

Furthermore, Kyle has obtained a certification as a Histotechnologist (HTL-ASCP) from the American Society of Clinical Pathology. Unfortunately, specific details regarding the timeline and institution of this certification are not provided.